Signs and Symptoms of Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma is serious form of blood cancer that impacts the lymphocytes (a particular kind of white blood cells). The worst and most recognizable feature of Non-Hodgkin’s lymphoma is the rapidly-increasing rate of growth of the lymphocytes which then proceed to crowd and ultimately damage the lymph nodes.

It’s worth noting, however, that contrary to what people generally assume because of the name of the disease, although Non-Hodgkin’s lymphoma spreads to the lymph tissue/nodes, that is not their starting point.

As with all diseases, a number of symptoms are typically associated with Non-Hodgkin’s lymphoma. Excessive sweating, to the point where clothing items appear to have been drenched in water while the person sleeps is a common indicator of Non-Hodgkin’s lymphoma. Similarly, the painless swelling of the lymph nodes in the neck, collarbone, armpits or groin is also a well-known flag. Size of this swelling is usually a key factor when it comes to analyzing the severity of the disease.

Other popular symptoms of Non-Hodgkin’s lymphoma include, but aren’t limited to: abdominal pain, chest pains, coughing fits, shortness of breath, fatigue, fever and excessive itching.

The tests utilized in order to determine whether or not someone is suffering from this disease are: blood tests, X-ray, MRI, CT scan and PET scans.

Like any other disease, the only surefire way to find out if you have developed it is consulting with your physician.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap